GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

GoodRx Holdings (Nasdaq: GDRX), the leading prescription savings platform in the U.S., has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. Company executives will engage in a fireside chat on Wednesday, January 15, 2025 at 9:45 a.m. Pacific Time (12:45 p.m. Eastern Time).

The event will be accessible via live webcast on GoodRx's Investor Relations website. An archived recording of the presentation will remain available on the company's website for a minimum of 30 days following the conference.

SANTA MONICA, Calif.--(BUSINESS WIRE)-- GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading prescription savings platform in the U.S., today announced that executives from the Company will participate in a fireside chat at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 15, 2025 at 9:45 a.m. Pacific Time (12:45 p.m. Eastern Time).

A live webcast will be available on the Company's Investor Relations website, https://investors.goodrx.com/. Following the conference, an archived recording will be available on the Company’s website for at least 30 days.

About GoodRx

GoodRx is the leading prescription savings platform in the U.S. Trusted by more than 25 million consumers and 750,000 healthcare professionals annually, GoodRx provides access to savings and affordability options for generic and brand-name medications at more than 70,000 pharmacies nationwide, as well as comprehensive healthcare research and information. Since 2011, GoodRx has helped consumers save over $75 billion on the cost of their prescriptions.

GoodRx periodically posts information that may be important to investors on its investor relations website at https://investors.goodrx.com. We intend to use our website as a means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors and potential investors are encouraged to consult GoodRx’s website regularly for important information, in addition to following GoodRx’s press releases, filings with the Securities and Exchange Commission and public conference calls and webcasts. The information contained on, or that may be accessed through, GoodRx’s website is not incorporated by reference into, and is not a part of, this press release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241218989923/en/

Investor Contact

GoodRx

Aubrey Reynolds

ir@goodrx.com

Press Contact

GoodRx

Lauren Casparis

lcasparis@goodrx.com

Source: GoodRx Holdings, Inc.

FAQ

When is GoodRx (GDRX) presenting at the 2025 J.P. Morgan Healthcare Conference?

GoodRx (GDRX) will present at the conference on Wednesday, January 15, 2025, at 9:45 a.m. Pacific Time (12:45 p.m. Eastern Time).

How can investors watch GoodRx's presentation at the 2025 J.P. Morgan Healthcare Conference?

Investors can watch the presentation via live webcast on GoodRx's Investor Relations website at https://investors.goodrx.com/.

How long will the recording of GoodRx's J.P. Morgan Healthcare Conference presentation be available?

The archived recording will be available on GoodRx's website for at least 30 days following the conference.

What type of presentation will GoodRx (GDRX) give at the 2025 J.P. Morgan Healthcare Conference?

GoodRx executives will participate in a fireside chat format presentation at the conference.